+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Employer and Workplace Drug Testing Market Size, Share & Trends Analysis Report by Type (Pre-employment drug screens, Post-employment), by Product (Consumables), by Mode, by Drug, by End Use, by Region, and Segment Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • August 2025
  • Region: Global
  • Grand View Research
  • ID: 6009914
The global employer and workplace drug testing market size was estimated at USD 6.10 billion in 2024 and is projected to reach 9.08 billion by 2033, growing at a CAGR of 4.6% from 2025 to 2033. This market focuses on detecting the presence of illicit drugs and controlled substances in biological samples to support workplace safety, regulatory compliance, and productivity.

Testing methods such as urine, oral fluid, hair, and blood analysis are widely used across industries, including transportation, manufacturing, construction, and energy, to reduce workplace accidents and absenteeism. Employer and workplace drug testing plays a significant role in pre-employment screening, random testing, and post-incident investigations, helping organizations maintain a safe and compliant workforce. The demand is driven by stricter government regulations, corporate policies promoting drug-free environments, and the availability of advanced rapid testing kits and laboratory-based confirmation methods. Growing awareness of substance abuse impacts on workforce performance and safety is further encouraging adoption across both developed and emerging markets.

According to a national survey by American Addiction Centers, 15.3% of U.S. workers reported working under the influence of alcohol, while 2.9% admitted to being under the influence of illicit drugs in 2024. These figures underscore a significant challenge for U.S. employers, highlighting the need for strong workplace drug testing policies. Furthermore, there is a growing emphasis on workplace safety and productivity, prompting organizations to adopt measures that ensure a drug-free environment. Rising awareness of the adverse effects of substance misuse in the workplace, including reduced productivity, increased absenteeism, workplace accidents, and legal liabilities, further drives demand for drug testing services.

Global Employer and Workplace Drug Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the global employer and workplace drug testing market on the basis of type, product, mode, drug, end use, and region:

Type Outlook (Revenue, USD Million, 2021-2033)

  • Pre-employment drug screens
  • Post-employment

Product Outlook (Revenue, USD Million, 2021-2033)

  • Consumables
  • Instruments
  • Rapid Testing Devices
  • Services

Mode Outlook (Revenue, USD Million, 2021-2033)

  • Urine
  • Hair
  • Oral Fluid
  • Instant testing

Drug Outlook (Revenue, USD Million, 2021-2033)

  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • LSD
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • IT/Finance
  • Manufacturing
  • Transportation
  • Construction
  • Retail and Hospitality
  • Healthcare
  • Education
  • Other Professional Services

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Type Segment
1.2.2. Product Segment
1.2.3. Mode Segment
1.2.4. Drug Segment
1.2.5. End-use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Global Employer and Workplace Drug Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising demand for pre-employment testing
3.2.1.2. Stringent laws mandating alcohol and drug testing in the workplace
3.2.1.3. Rising prevalence of substance use in the workplace
3.2.2. Market restraint analysis
3.2.2.1. Changing legal environment and changing societal norms
3.2.3. Market opportunity analysis
3.2.3.1. Technological advancement in drug testing for workplace
3.3. Global Employer and Workplace Drug Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Global Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Employer and Workplace Drug Testing Market Type Movement Analysis
4.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by type, 2021 to 2033 (USD Million)
4.4. Pre-employment Drug Screens
4.4.1. Pre-employment drug screens market estimates and forecasts, 2021 to 2033 (USD Million)
4.5. Post-employment
4.5.1. Post-employment market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Global Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Employer and Workplace Drug Testing Market Product Movement Analysis
5.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
5.4. Consumables
5.4.1. Consumables market estimates and forecasts, 2021 to 2033 (USD Million)
5.5. Instruments
5.5.1. Instruments market estimates and forecasts, 2021 to 2033 (USD Million)
5.6. Rapid Testing Devices
5.6.1. Rapid testing devices market estimates and forecasts, 2021 to 2033 (USD Million)
5.7. Services
5.7.1. Services market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. Global Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Employer and Workplace Drug Testing Market Mode Movement Analysis
6.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by mode, 2021 to 2033 (USD Million)
6.4. Urine
6.4.1. Urine market estimates and forecasts, 2021 to 2033 (USD Million)
6.5. Hair
6.5.1. Hair market estimates and forecasts, 2021 to 2033 (USD Million)
6.6. Oral Fluid
6.6.1. Oral fluid market estimates and forecasts, 2021 to 2033 (USD Million)
6.7. Instant testing
6.7.1. Instant testing market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 7. Global Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Employer and Workplace Drug Testing Market Drug Movement Analysis
7.2.1. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by drug, 2021 to 2033 (USD Million)
7.3. Alcohol
7.3.1. Alcohol market estimates and forecasts, 2021 to 2033 (USD Million)
7.4. Cannabis/Marijuana
7.4.1. Cannabis/marijuana market estimates and forecasts, 2021 to 2033 (USD Million)
7.5. Cocaine
7.5.1. Cocaine market estimates and forecasts, 2021 to 2033 (USD Million)
7.6. Opioids
7.6.1. Opioids testing market estimates and forecasts, 2021 to 2033 (USD Million)
7.7. Amphetamine & Methamphetamine
7.7.1. Amphetamine & methamphetamine market estimates and forecasts, 2021 to 2033 (USD Million)
7.8. LSD
7.8.1. LSD market estimates and forecasts, 2021 to 2033 (USD Million)
7.9. Others
7.9.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 8. Global Employer and Workplace Drug Testing Market: End-use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Employer and Workplace Drug Testing Market End-use Movement Analysis
8.2.1. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Million)
8.3. IT/Finance
8.3.1. IT/finance market estimates and forecasts, 2021 to 2033 (USD Million)
8.4. Manufacturing
8.4.1. Manufacturing market estimates and forecasts, 2021 to 2033 (USD Million)
8.5. Transportation
8.5.1. Transportation market estimates and forecasts, 2021 to 2033 (USD Million)
8.6. Construction
8.6.1. Construction market estimates and forecasts, 2021 to 2033 (USD Million)
8.7. Retail and Hospitality
8.7.1. Retail and hospitality market estimates and forecasts, 2021 to 2033 (USD Million)
8.8. Healthcare
8.8.1. Healthcare market estimates and forecasts, 2021 to 2033 (USD Million)
8.9. Education
8.9.1. Education surgical centers market estimates and forecasts, 2021 to 2033 (USD Million)
8.10. Other Professional Services
8.10.1. Other Professional Services market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 9. Employer and Workplace Drug Testing Market: Regional Estimates & Trend Analysis
9.1. Regional Dashboard
9.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
9.3. North America
9.3.1. U.S.
9.3.1.1. Key country dynamics
9.3.1.2. Regulatory framework/ reimbursement structure
9.3.1.3. Competitive scenario
9.3.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
9.3.2. Canada
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework/ reimbursement structure
9.3.2.3. Competitive scenario
9.3.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
9.3.3. Mexico
9.3.3.1. Key country dynamics
9.3.3.2. Regulatory framework/ reimbursement structure
9.3.3.3. Competitive scenario
9.3.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework/ reimbursement structure
9.4.1.3. Competitive scenario
9.4.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework/ reimbursement structure
9.4.2.3. Competitive scenario
9.4.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework/ reimbursement structure
9.4.3.3. Competitive scenario
9.4.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework/ reimbursement structure
9.4.4.3. Competitive scenario
9.4.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework/ reimbursement structure
9.4.5.3. Competitive scenario
9.4.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
9.4.6. Norway
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework/ reimbursement structure
9.4.6.3. Competitive scenario
9.4.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework/ reimbursement structure
9.4.7.3. Competitive scenario
9.4.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
9.4.8. Denmark
9.4.8.1. Key country dynamics
9.4.8.2. Regulatory framework/ reimbursement structure
9.4.8.3. Competitive scenario
9.4.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
9.5. Asia-Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
9.5.3. India
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework/ reimbursement structure
9.5.3.3. Competitive scenario
9.5.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
9.5.4. Australia
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework/ reimbursement structure
9.5.4.3. Competitive scenario
9.5.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework/ reimbursement structure
9.5.5.3. Competitive scenario
9.5.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework/ reimbursement structure
9.5.6.3. Competitive scenario
9.5.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
9.6.2. Argentina
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Share Analysis, 2024
10.4. List of Key Certification Providers/Scheme Owners
10.5. Company Profiles/Listing
10.5.1. First Advantage
10.5.1.1. Company overview
10.5.1.2. Financial performance
10.5.1.3. Product benchmarking
10.5.1.4. Strategic initiatives
10.5.2. Laboratory Corporation of America Holdings (Labcorp)
10.5.2.1. Company overview
10.5.2.2. Financial performance
10.5.2.3. Product benchmarking
10.5.2.4. Strategic initiatives
10.5.3. Drägerwerk AG & Co. KGaA
10.5.3.1. Company overview
10.5.3.2. Financial performance
10.5.3.3. Product benchmarking
10.5.3.4. Strategic initiatives
10.5.4. Bio-Rad Laboratories, Inc.
10.5.4.1. Company overview
10.5.4.2. Financial performance
10.5.4.3. Product benchmarking
10.5.4.4. Strategic initiatives
10.5.5. Abbott
10.5.5.1. Company overview
10.5.5.2. Financial performance
10.5.5.3. Product benchmarking
10.5.5.4. Strategic initiatives
10.5.6. Clinical Reference Laboratory Inc.
10.5.6.1. Company overview
10.5.6.2. Financial performance
10.5.6.3. Product benchmarking
10.5.6.4. Strategic initiatives
10.5.7. Quest Diagnostics
10.5.7.1. Company overview
10.5.7.2. Financial performance
10.5.7.3. Product benchmarking
10.5.7.4. Strategic initiatives
10.5.8. Cordant Health Solutions
10.5.8.1. Company overview
10.5.8.2. Financial performance
10.5.8.3. Product benchmarking
10.5.8.4. Strategic initiatives
10.5.9. DISA Global Solutions
10.5.9.1. Company overview
10.5.9.2. Financial performance
10.5.9.3. Product benchmarking
10.5.9.4. Strategic initiatives
10.5.10. HireRight, LLC
10.5.10.1. Company overview
10.5.10.2. Financial performance
10.5.10.3. Product benchmarking
10.5.10.4. Strategic initiatives
10.5.11. OraSure Technologies, Inc.
10.5.11.1. Company overview
10.5.11.2. Financial performance
10.5.11.3. Product benchmarking
10.5.11.4. Strategic initiatives
10.5.12. Psychemedics Corporation
10.5.12.1. Company overview
10.5.12.2. Financial performance
10.5.12.3. Product benchmarking
10.5.12.4. Strategic initiatives
10.5.13. Omega Laboratories
10.5.13.1. Company overview
10.5.13.2. Financial performance
10.5.13.3. Product benchmarking
10.5.13.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 U.S. employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 4 U.S. employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 5 U.S. employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 6 U.S. employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 7 U.S. employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 8 North America employer and workplace drug testing market, by region, 2021-2033 (USD Million)
Table 9 North America employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 10 North America employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 11 North America employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 12 North America employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 13 North America employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 14 Canada employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 15 Canada employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 16 Canada employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 17 Canada employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 18 Canada employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 19 Mexico employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 20 Mexico employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 21 Mexico employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 22 Mexico employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 23 Mexico employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 24 Europe employer and workplace drug testing market, by region, 2021-2033 (USD Million)
Table 25 Europe employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 26 Europe employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 27 Europe employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 28 Europe employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 29 Europe employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 30 UK employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 31 UK employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 32 UK employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 33 UK employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 34 UK employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 35 Germany employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 36 Germany employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 37 Germany employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 38 Germany employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 39 Germany employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 40 France employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 41 France employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 42 France employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 43 France employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 44 France employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 45 Italy employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 46 Italy employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 47 Italy employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 48 Italy employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 49 Italy employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 50 Spain employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 51 Spain employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 52 Spain employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 53 Spain employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 54 Spain employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 55 Denmark employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 56 Denmark employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 57 Denmark employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 58 Denmark employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 59 Denmark employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 60 Sweden employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 61 Sweden employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 62 Sweden employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 63 Sweden employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 64 Sweden employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 65 Norway employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 66 Norway employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 67 Norway employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 68 Norway employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 69 Norway employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 70 Asia-Pacific employer and workplace drug testing market, by region, 2021-2033 (USD Million)
Table 71 Asia-Pacific employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 72 Asia-Pacific employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 73 Asia-Pacific employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 74 Asia-Pacific employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 75 Asia-Pacific employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 76 Japan employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 77 Japan employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 78 Japan employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 79 Japan employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 80 Japan employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 81 China employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 82 China employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 83 China employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 84 China employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 85 China employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 86 India employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 87 India employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 88 India employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 89 India employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 90 India employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 91 Australia employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 92 Australia employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 93 Australia employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 94 Australia employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 95 Australia employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 96 South Korea employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 97 South Korea employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 98 South Korea employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 99 South Korea employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 100 South Korea employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 101 Thailand employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 102 Thailand employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 103 Thailand employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 104 Thailand employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 105 Thailand employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 106 Latin America employer and workplace drug testing market, by region, 2021-2033 (USD Million)
Table 107 Latin America employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 108 Latin America employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 109 Latin America employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 110 Latin America employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 111 Latin America employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 112 Brazil employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 113 Brazil employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 114 Brazil employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 115 Brazil employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 116 Brazil employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 117 Argentina employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 118 Argentina employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 119 Argentina employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 120 Argentina employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 121 Argentina employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 122 MEA employer and workplace drug testing market, by region, 2021-2033 (USD Million)
Table 123 MEA employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 124 MEA employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 125 MEA employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 126 MEA employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 127 MEA employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 128 South Africa employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 129 South Africa employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 130 South Africa employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 131 South Africa employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 132 South Africa employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 133 Saudi Arabia employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 134 Saudi Arabia employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 135 Saudi Arabia employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 136 Saudi Arabia employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 137 Saudi Arabia employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 138 UAE employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 139 UAE employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 140 UAE employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 141 UAE employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 142 global employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
Table 143 Kuwait employer and workplace drug testing market, by type, 2021-2033 (USD Million)
Table 144 Kuwait employer and workplace drug testing market, by product, 2021-2033 (USD Million)
Table 145 Kuwait employer and workplace drug testing market, by mode, 2021-2033 (USD Million)
Table 146 Kuwait employer and workplace drug testing market, by drug, 2021-2033 (USD Million)
Table 147 Kuwait employer and workplace drug testing market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Global employer and workplace drug testing market segmentation
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validating & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot-1
Figure 14 Segment snapshot-2
Figure 15 Competitive landscape snapshot
Figure 16 Market trends & outlook
Figure 17 Porter’s five force analysis
Figure 18 PESTEL analysis
Figure 19 Global employer and workplace drug testing market: Type outlook key takeaways
Figure 20 Global employer and workplace drug testing market: Type movement analysis
Figure 21 Pre-employment drug screens market estimates and forecasts, 2021-2033 (USD Million)
Figure 22 Post-employment market estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Global employer and workplace drug testing market: Product outlook key takeaways
Figure 24 Global employer and workplace drug testing market: Product movement analysis
Figure 25 Consumables market estimates and forecasts, 2021-2033 (USD Million)
Figure 26 Instruments market estimates and forecasts, 2021-2033 (USD Million)
Figure 27 Rapid testing devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Services market estimates and forecasts, 2021-2033 (USD Million)
Figure 29 Global employer and workplace drug testing market: Mode outlook key takeaways
Figure 30 Global employer and workplace drug testing market: Mode movement analysis
Figure 31 Urine market estimates and forecasts, 2021-2033 (USD Million)
Figure 32 Hair market estimates and forecasts, 2021-2033 (USD Million)
Figure 33 Oral fluid market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 Instant testing estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Global employer and workplace drug testing market: Mode outlook key takeaways
Figure 36 Global employer and workplace drug testing market: Mode movement analysis
Figure 37 Alcohol market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 Cannabis/marijuana market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 Cocaine market estimates and forecasts, 2021-2033 (USD Million)
Figure 40 Opioids estimates and forecasts, 2021-2033 (USD Million)
Figure 41 Amphetamine & methamphetamine market estimates and forecasts, 2021-2033 (USD Million)
Figure 42 LSD market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Global employer and workplace drug testing market: End-use outlook key takeaways
Figure 45 Global employer and workplace drug testing market: End-use movement analysis
Figure 46 IT/finance market estimates and forecasts, 2021-2033 (USD Million)
Figure 47 Manufacturing market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Transportation market estimates and forecasts, 2021-2033 (USD Million)
Figure 49 Construction estimates and forecasts, 2021-2033 (USD Million)
Figure 50 Retail and hospitality market estimates and forecasts, 2021-2033 (USD Million)
Figure 51 Healthcare market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Education market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 Other professional services market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Employer and Workplace Drug Testing Market: Regional outlook and key takeaways
Figure 55 Regional outlook, 2024 & 2033
Figure 56 North America
Figure 57 North America market estimates and forecast, 2021-2033 (USD Million)
Figure 58 U.S. key country dynamics
Figure 59 U.S. market estimates and forecast, 2021-2033 (USD Million)
Figure 60 Canada key country dynamics
Figure 61 Canada market estimates and forecast, 2021-2033 (USD Million)
Figure 62 Europe
Figure 63 Europe market estimates and forecast, 2021-2033 (USD Million)
Figure 64 UK key country dynamics
Figure 65 UK market estimates and forecast, 2021-2033 (USD Million)
Figure 66 Germany
Figure 67 Germany market estimates and forecast, 2021-2033 (USD Million)
Figure 68 France key country dynamics
Figure 69 France market estimates and forecast, 2021-2033 (USD Million)
Figure 70 Italy key country dynamics
Figure 71 Italy market estimates and forecast, 2021-2033 (USD Million)
Figure 72 Spain key country dynamics
Figure 73 Spain market estimates and forecast, 2021-2033 (USD Million)
Figure 74 Denmark key country dynamics
Figure 75 Denmark market estimates and forecast, 2021-2033 (USD Million)
Figure 76 Sweden key country dynamics
Figure 77 Sweden market estimates and forecast, 2021-2033 (USD Million)
Figure 78 Norway key country dynamics
Figure 79 Norway market estimates and forecast, 2021-2033 (USD Million)
Figure 80 Asia-Pacific
Figure 81 Asia-Pacific market estimates and forecast, 2021-2033 (USD Million)
Figure 82 Japan key country dynamics
Figure 83 Japan market estimates and forecast, 2021-2033(USD Million)
Figure 84 China key country dynamics
Figure 85 China market estimates and forecast, 2021-2033 (USD Million)
Figure 86 India key country dynamics
Figure 87 India market estimates and forecast, 2021-2033 (USD Million)
Figure 88 South Korea key country dynamics
Figure 89 South Korea market estimates and forecast, 2021-2033 (USD Million)
Figure 90 Australia key country dynamics
Figure 91 Australia market estimates and forecast, 2021-2033 (USD Million)
Figure 92 Thailand key country dynamics
Figure 93 Thailand market estimates and forecast, 2021-2033 (USD Million)
Figure 94 Latin America
Figure 95 Latin America market estimates and forecast, 2021-2033 (USD Million)
Figure 96 Brazil key country dynamics
Figure 97 Brazil market estimates and forecast, 2021-2033 (USD Million)
Figure 98 Mexico key country dynamics
Figure 99 Mexico market estimates and forecast, 2021-2033 (USD Million)
Figure 100 Argentina key country dynamics
Figure 101 Argentina market estimates and forecast, 2021-2033 (USD Million)
Figure 102 Middle East & Africa
Figure 103 MEA market estimates and forecast, 2021-2033 (USD Million)
Figure 104 South Africa key country dynamics
Figure 105 South Africa market estimates and forecast, 2021-2033 (USD Million)
Figure 106 Saudi Arabia key country dynamics
Figure 107 Saudi Arabia market estimates and forecast, 2021-2033 (USD Million)
Figure 108 UAE key country dynamics
Figure 109 UAE market estimates and forecast, 2021-2033 (USD Million)
Figure 110 Kuwait key country dynamics
Figure 111 Kuwait market estimates and forecast, 2021-2033 (USD Million)
Figure 112 Market differentiators
Figure 113 Key company market share analysis, 2024

Companies Mentioned

The major companies profiled in this Employer and Workplace Drug Testing market report include:
  • First Advantage
  • Laboratory Corporation of America Holdings (Labcorp)
  • Drägerwerk AG & Co. KGaA
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Clinical Reference Laboratory Inc.
  • Quest Diagnostics
  • Cordant Health Solutions
  • DISA Global Solutions
  • HireRight, LLC
  • OraSure Technologies, Inc.
  • Omega Laboratories
  • Psychemedics Corporation

Table Information